What is the cause of heart fluttering that occurs when continuous positive airway pressure (CPAP) is initiated in a patient without anxiety, and how should it be evaluated and managed?

Heart Fluttering with CPAP Initiation: Evaluation and Management

Heart fluttering when CPAP is initiated is most likely a benign physiological response to changes in intrathoracic pressure and autonomic modulation, but requires evaluation to exclude underlying cardiac arrhythmias, particularly atrial fibrillation, and assessment of CPAP pressure settings.

Understanding the Mechanism

CPAP directly affects cardiac autonomic modulation through multiple pathways. When positive pressure is applied to the airway, it alters:

• Intrathoracic pressure dynamics - affecting venous return and cardiac preload
• Autonomic nervous system balance - modulating heart rate variability
• Baroreceptor stimulation - through blood pressure fluctuations

Research demonstrates that CPAP causes measurable changes in heart rate variability during therapy. In patients with heart failure and central sleep apnea, CPAP significantly decreased heart rate variability parameters (SDNN, RMSSD, and spectral power) during treatment 1. Similarly, healthy volunteers showed increased heart rate variability with CPAP application, mediated by enhanced blood pressure oscillations and altered baroreflex sensitivity 2.

Immediate Evaluation Steps

Check the CPAP pressure settings first. The standard starting pressure is 4 cm H₂O for adults 3. If the patient is experiencing discomfort or intolerance at higher pressures, this could manifest as palpitations. Consider whether:

• The pressure is too high for initial tolerance
• Rapid pressure changes are occurring (if using auto-titrating CPAP)
• The mask fit is poor, causing pressure fluctuations

Obtain a 12-lead ECG and consider ambulatory monitoring. While anxiety is reportedly absent, palpitations during CPAP initiation warrant exclusion of:

• Atrial fibrillation - OSA is highly prevalent in AF patients, and untreated OSA increases AF recurrence risk 4, 5
• Premature ventricular contractions - which can be reduced by CPAP in heart failure patients 6
• Other arrhythmias triggered by autonomic changes

Risk Stratification

Assess for underlying cardiac conditions:

• Heart failure - CPAP affects cardiac hemodynamics differently in heart failure patients. While it can improve autonomic function over time 7, acute initiation may cause transient hemodynamic changes
• Obstructive sleep apnea severity - Higher AHI correlates with greater autonomic dysfunction
• Cardiovascular comorbidities - Hypertension, coronary disease, or structural heart disease

Management Algorithm

If ECG shows no acute arrhythmia:

1. Reduce CPAP pressure temporarily - Start at the minimum 4 cm H₂O and titrate up gradually over multiple nights rather than achieving target pressure immediately
2. Consider bilevel PAP (BPAP) - If the patient remains intolerant of CPAP pressures, switch to BPAP with starting IPAP 8 cm H₂O and EPAP 4 cm H₂O 3. The differential pressure may be better tolerated
3. Ensure proper acclimatization - Guidelines emphasize that all PAP candidates should receive adequate education, hands-on demonstration, careful mask fitting, and acclimatization prior to titration 3

If palpitations persist despite pressure adjustment:

• Arrange attended polysomnography with manual CPAP titration to observe cardiac rhythm during pressure changes
• Consider 24-48 hour Holter monitoring during CPAP use
• Evaluate for treatment-emergent central sleep apnea, which may require different PAP modalities 8

Important Caveats

The sensation of "fluttering" may represent:

• Increased awareness of normal heart rate variability changes induced by CPAP
• Actual ectopic beats (PACs or PVCs) triggered by autonomic shifts
• Hemodynamic changes from altered venous return

Do not dismiss symptoms even without anxiety. While anxiety commonly causes palpitations, the temporal relationship with CPAP initiation suggests a physiological rather than psychological etiology.

Monitor for improvement over time. Studies show that chronic CPAP therapy actually improves cardiac autonomic function and reduces ventricular arrhythmias in heart failure patients 6, 7. Initial palpitations may resolve as the cardiovascular system adapts to therapy.

When to Escalate Care

Refer to cardiology if:

• Documented arrhythmias on monitoring
• Symptoms accompanied by chest pain, dyspnea, or syncope
• Known structural heart disease or heart failure
• Palpitations persist beyond 2-4 weeks of appropriate CPAP titration

The goal is to achieve effective OSA treatment while ensuring cardiovascular safety, as untreated OSA significantly worsens cardiovascular outcomes and AF recurrence 4, 5, 9.